Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1168-2025

Brand Name: MediHoney Gel Product Name: MediHoney Wound & Burn Dressing Gel Recall

Brand Name: MediHoney¿ Gel Product Name: MediHoney¿ Wound & Burn Dressing Gel Model/Catalog Number: 31815 Software Version: N/A Product Description: MediHoney¿ Gel with Active Leptospermum Honey is a moist dressing made of Active Leptospermum Honey in combination with gelling agents. The gelling agents act to maintain the physical integrity and viscosity of the dressing upon application. As a percentage of the overall dressing, MediHoney Gel dressing contains 80% medical grade honey by weight. The dressing helps maintain a moist environment conducive to wound healing and helps aid and support autolytic debridement. The dressing can be removed without causing trauma to the wound when a primary dressing is used. Component: No

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: MediHoney Gel Product Name: MediHoney Wound & Burn Dressing Gel. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1168-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jan 10, 2025
FDA report date
Feb 19, 2025
Quantity in commerce
12,166 units
Distribution
See key details
FDA cause
Process control

What is being recalled?

Brand Name: MediHoney Gel Product Name: MediHoney Wound & Burn Dressing Gel Model/Catalog Number: 31815 Software Version: N/A Product Description: MediHoney Gel with Active Leptospermum Honey is a moist dressing made of Active Leptospermum Honey in combination with gelling agents. The gelling agents act to maintain the physical integrity and viscosity of the dressing upon application. As a percentage of the overall dressing, MediHoney Gel dressing contains 80% medical grade honey by weight. The dressing helps maintain a moist environment conducive to wound healing and helps aid and support autolytic debridement. The dressing can be removed without causing trauma to the wound when a primary dressing is used. Component: No

Affected model & UDI checker

Search the exact identifiers published for Z-1168-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
31815Brand Name: MediHoney Gel Product Name: MediHoney Wound & Burn Dressing GelCheck source noticeNot specified
FDA code information

Model/Catalog Number: 31815; UDI #: 10381780486886; Lot #s: 2328, 2332 and 2333;

View the original FDA recall notice

Why was this product recalled?

Potential that the induction seal is not completely sealed to the device tube packaging.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Integra Lifesciences Corp. take?

On January 10, 2025 URGENT MEDICAL DEVICE RECALL letters were sent to customers. Actions to be Taken by Customers (Medical Facility): 1. If you do not have affected product, check the box, I do not have affected product. 2. If you do have units of the affected product (Table 1), remove them immediately from service and quarantine them. 3. If you do have affected product, check the box on the enclosed Acknowledgement Form I do have affected product. Record the total quantity of the affected product that you have. 4. Forward this notice to those who utilize the product so they are aware of this recall and can identify any affected product that may remain in clinical areas. 5. Complete and return the Medical Facility Acknowledgement Form to FCA3@integralife.com or FAX to 1-609- 750-4220. 6. Keep a copy of the form for your records. 7. When the form from you is received, and it is noted that you have affected product, Customer Service will contact you and provide an RMA number and directions to return the product. You can request a credit for the quantities returned. Actions to be Taken by Distributors: 1. If you do not have affected product, check the box, I do not have affected product. 2. If you do have the affected product (Table 1), remove the product from further distribution. 3. If you do have affected product, check the box I do have affected product. Record the total quantity of affected product you have. 4. Please check your customer traceability records for shipments of above catalog and lot numbers. 5. Forward this notice to any of your customers that have purchased the affected product (Table 1). 6. Complete and return the Distributor Acknowledgement Form to FCA3@integralife.com or FAX to 1-609-750- 4220. 7. Keep a copy of the form for your records. 8. When the form from you and/or your customer is received, and it is noted that you and/or your customer has affected product, Customer Service will contact you and/or your customer and provide an RMA n

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology